Patents by Inventor Gary Grubb

Gary Grubb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
    Publication number: 20080114050
    Abstract: Pyrrole-oxindole derivatives useful as progesterone receptor antagonists, and methods for preparing the same, are provided. Pharmaceutical compositions containing these derivatives are described, as is the use thereof in contraception and hormone-related conditions.
    Type: Application
    Filed: November 16, 2007
    Publication date: May 15, 2008
    Applicant: Wyeth
    Inventors: Andrew Fensome, Casey McComas, Edward Melenski, Michael Marella, Jay Wrobel, Gary Grubb
  • Compositions and methods for treatment of cycle-related symptoms
    Publication number: 20070009594
    Abstract: Methods are provided for treating cycle-related symptoms through administration of at least one progestin and at least one estrogen to a female subject.
    Type: Application
    Filed: June 26, 2006
    Publication date: January 11, 2007
    Applicant: Wyeth
    Inventors: Gary Grubb, Ginger Constantine
  • Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
    Publication number: 20060030717
    Abstract: Pyrrole-oxindole derivatives useful as progesterone receptor antagonists, and methods for preparing the same, are provided. Pharmaceutical compositions containing these derivatives are described, as is the use thereof in contraception and hormone-related conditions.
    Type: Application
    Filed: July 6, 2005
    Publication date: February 9, 2006
    Applicant: Wyeth
    Inventors: Andrew Fensome, Casey McComas, Edward Melenski, Michael Marella, Jay Wrobel, Gary Grubb
  • Cyclic progestin regimens and kits
    Publication number: 20060009428
    Abstract: A method of contraception is provided which involves delivery of 21 to 27 consecutive days of a progestin in the absence of an estrogen or other steroidal compound, followed by 1 to 7 days without an effective amount of an active agent. Also described is a pharmaceutically useful kit to facilitate delivery of this regimen.
    Type: Application
    Filed: July 6, 2005
    Publication date: January 12, 2006
    Applicant: Wyeth
    Inventors: Gary Grubb, Ginger Constantine
  • Progesterone receptor antagonists, contraceptive regimens, and kits
    Publication number: 20060009509
    Abstract: A method of contraception is provided which involves delivery of 21 to 27 consecutive days of one or more PR antagonists in the absence of a progestin, estrogen, or other steroidal compound, followed by 1 to 7 days without any active agent. Also described is a pharmaceutically useful kit to facilitate delivery of this regimen.
    Type: Application
    Filed: July 6, 2005
    Publication date: January 12, 2006
    Applicant: Wyeth
    Inventors: Gary Grubb, Ginger Constantine, Andrew Fensome, Casey McComas, Edward Melenski, Michael Marella, Jay Wrobel
  • Compositions and methods for treatment of premenstrual dysphoric disorder
    Publication number: 20050272712
    Abstract: The present invention relates to a method for treating premenstrual dysphoric disorder through administration of at least one progestin and at least one estrogen to a female subject.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 8, 2005
    Applicant: Wyeth
    Inventors: Gary Grubb, Ginger Constantine, Karen Walsh, Diane Harrison